Welcome to Respeutics B.V. – Revolutionizing Respiratory Care
Founded in 2024 by renowned healthcare pioneers Dr. Jyoti Botchu and Dr. Babu Kurakula, Respeutics B.V. was born from a shared vision to advance respiratory
healthcare through groundbreaking innovation. Our mission is clear: to develop cutting-edge Metered Dose Inhalers (MDIs) that not only deliver exceptional
therapeutic results but also set new standards for sustainability and ease of use. At Respeutics B.V., we are committed to transforming the lives of patients worldwide
by pushing the boundaries of inhalation technology.
Company Overview
At Respeutics B.V., we are driven by our passion for improving respiratory health. Our journey began with the goal of addressing the limitations of traditional inhalers,
which often fail to provide precise, efficient, and patient-friendly solutions. Our innovative MDIs are designed to overcome these challenges by offering enhanced
drug delivery, real-time tracking, and a biodegradable, reusable design. With a focus on user convenience and environmental responsibility, we are proud to lead the
charge in revolutionizing inhalation therapy.
Our mission is twofold
At Respeutics B.V., we envision a world where respiratory healthcare is efficient, patient-friendly, and sustainable. Our goal is to revolutionize inhalation therapy by developing products that provide better drug delivery, reduce side effects, and support environmental sustainability.
- Deliver groundbreaking, patient-centric inhalation therapies that enhance treatment outcomes and improve quality of life.
- Prioritize sustainability through eco-friendly product designs, ensuring a healthier planet for future generations.
Global Presence
Respeutics B.V. is a truly global company with research and development facilities strategically located in both The Netherlands and India. Our R&D center in The Netherlands focuses on cutting-edge product innovation, leveraging advanced scientific research and engineering expertise to design state-of-the-art inhalation devices. Meanwhile, our facility in India is dedicated to optimizing manufacturing processes, ensuring that our inhalers meet the highest international standards while remaining cost-effective and accessible to patients worldwide.
This dual presence allows us to harness the strengths of both regions—Europe’s technological innovation and India’s manufacturing efficiency—making us a global leader in respiratory care.
Dr. Jyoti Botchu – Co-Founder
Dr. Jyoti Botchu, co-founder of Respeutics B.V., is an accomplished Aerospace and Chemical scientist known for her groundbreaking work in gel propulsion technology. Her expertise in precision fuel delivery for rockets has been ingeniously applied to the development of Respeutics’ Metered Dose Inhalers (MDIs). By leveraging the same principles used in advanced rocket propulsion—such as controlled and efficient gel propellant injections—Dr. Jyoti has pioneered an MDI that delivers precise doses of medication deep into the lungs, ensuring maximum therapeutic benefit and fewer side effects. This innovative approach has set a new standard in respiratory care, offering a level of drug delivery control previously unseen in traditional inhalers.
Dr. Jyoti’s deep commitment to sustainability is another driving force behind the innovative MDI technology. With her vast experience in green energy projects, including leading a €10 million Power2Hype project to create sustainable hydrogen peroxide production methods, she has introduced eco-friendly features to Respeutics’ inhalers. These MDIs are not only efficient in delivering medication but are also biodegradable and reusable, aligning with her vision for greener healthcare solutions. Dr. Jyoti’s focus on sustainability reflects her broader goal of advancing medical devices that meet both patient needs and environmental standards.
In addition to her work at Respeutics, Dr. Jyoti has and her team invented the world’s first Hydrogen Peroxide Concentrator—an achievement with wide-reaching applications in industries like space propulsion. Her academic career as an Associate Professor in Space Systems Engineering at TU Delft University further demonstrates her passion for applying high-tech solutions to real-world challenges. Dr. Jyoti’s cross-disciplinary expertise, innovative mindset, and recognition as one of the ‘Top 10 Indian Leaders in Europe – 2023’ by CEO Insights solidify her as a leading figure in transforming both respiratory healthcare and sustainable innovation.
Dr. Babu Kurakula – Co-Founder
Dr. Babu Kurakula, co-founder of Respeutics B.V., is a renowned expert in pulmonology research, with a focus on identifying and validating new APIs (Active Pharmaceutical Ingredients) to treat pulmonary arterial hypertension (PAH). With a Ph.D. from Amsterdam UMC, his work has significantly advanced the understanding of molecular mechanisms underlying vascular remodelling in the lungs and right ventricle dysfunction in PAH patients. Leveraging his extensive research in the field, Dr. Kurakula has played a crucial role in the development of Respeutics’ innovative Metered Dose Inhaler (MDI), designed to deliver cutting-edge therapies more effectively to the lungs, offering new hope to patients with chronic respiratory conditions.
A key focus of Dr. Kurakula’s research is identifying sex-specific targets to better treat PAH, a condition with a strong female preponderance. By studying the role of sex hormones, sex chromosomes, and signalling pathways such as ER/BMPR2, his lab has made significant strides in developing sex-specific therapies that address the unique molecular mechanisms in female PAH patients. Two of the compounds identified by Dr. Kurakula’s team have shown promising results in proof-of-concept clinical trials, demonstrating his ability to translate scientific discoveries into real-world treatments. This cutting-edge research has directly informed the development of Respeutics’ MDIs, ensuring that the inhalers are not only innovative in design but also capable of delivering targeted, precise therapies for conditions like PAH.
Dr. Kurakula’s expertise also extends to other forms of pulmonary hypertension, such as chronic thromboembolic pulmonary hypertension (CTEPH). His lab has identified several key proteins that regulate endothelial cell dysfunction and coagulation in CTEPH patients, which may lead to novel treatments for this complex condition. His pioneering research in pulmonary vascular diseases, combined with his passion for advancing patient care, positions Dr. Kurakula at the forefront of Respeutics’ mission to revolutionize respiratory healthcare through innovative MDIs that deliver advanced, targeted therapies for a range of pulmonary conditions.
Dr. Teja Avula – CEO
Dr. Teja Avula, CEO of Respeutics B.V., is a visionary business leader with a deep commitment to sustainability and innovation. With his entrepreneurial mindset and expertise, Dr. Avula spearheads the development of RespeutXTM Inhaler, a cutting-edge Metered Dose Inhaler (MDI) that is as environmentally responsible as it is medically effective. Under his leadership, Respeutics is transforming the respiratory healthcare industry by designing biodegradable and reusable MDIs, setting new standards for sustainable medical devices.
Dr. Avula’s impressive track record includes serving as CEO of a leading renewable energy company, where he led its transformation from a startup to a multimillion-dollar enterprise with global reach. His experience in solar energy production and sustainability is now driving Respeutics’ mission to reduce the environmental impact of inhalers while improving patient outcomes. By introducing MDIs that incorporate reusable components and biodegradable materials, RespeutXTM Inhaler addresses the growing demand for sustainable healthcare solutions without compromising on performance or patient care.
As a strategic leader, Dr. Avula has forged partnerships with government enterprises and Fortune 500 companies, fostering collaboration to bring innovative solutions to market. His background in sustainability is further strengthened by his role as Agriculture Policy and Advocacy Manager for India’s largest nonprofit agriculture organization, where he represented over 15,000 farmers. With a Master’s degree from the U.K. and a Ph.D. from the University of Amsterdam, Dr. Avula’s extensive international experience and leadership are driving Respeutics B.V. to the forefront of sustainable respiratory care, setting the stage for a future where ecofriendly inhalation technology like RespeutXTM Inhaler revolutionizes the industry.
Dr. Aishwarya Rajeev – Chief Marketing Officer
Dr. Aishwarya Rajeev, with her background as a dental doctor, brings a distinctive and valuable perspective to her role as the Chief Marketing Officer (CMO) at Respeutics B.V. Her journey from dentistry to marketing is driven by a passion for sustainable healthcare solutions and a deep understanding of patient needs and consumer behavior. As the head of the marketing division, Dr. Aishwarya is at the forefront of promoting RespeutX, our revolutionary Metered Dose Inhaler (MDI), with a focus on sustainability and innovation. With her expertise, she has built impactful campaigns that connect with both healthcare professionals and consumers, championing the benefits of eco-friendly healthcare technologies.
Dr. Aishwarya’s background in dental sciences has equipped her with strong skills in research, analysis, and patient communication, all of which translate seamlessly into the field of marketing. Her deep understanding of healthcare challenges and market dynamics allows her to craft marketing strategies that resonate with audiences, while her passion for sustainability drives her to promote products that align with the future of eco-friendly healthcare. In her role, Dr. Aishwarya ensures that the messaging around RespeutX’s biodegradable and reusable features is communicated effectively, highlighting the device’s ability to reduce environmental impact while providing cutting-edge respiratory care.
Beyond marketing, Dr. Aishwarya plays a crucial role in the development of RespeutX itself, applying her healthcare background to inform product design and innovation. She understands the intersection of healthcare and sustainability and leverages her knowledge to ensure that the product meets the needs of both patients and the planet. Her ability to merge dental healthcare insights with sustainable marketing strategies has made her a key driving force behind our company’s mission to revolutionize respiratory care through environmentally responsible solutions. Dr. Aishwarya holds a Bachelor’s and Master’s degree in Dental Surgery from KLE University, adding depth to her role in shaping Respeutics’ sustainable future.